Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-11-03
1979-11-06
Torrence, Dolph H.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
548247, 260429R, 260465E, 260465F, 260465G, 260465R, 2604656, 260544D, 2605705C, 546230, A61K 31275, C07C12176
Patent
active
041736508
ABSTRACT:
This disclosure describes new compounds and compositions of matter useful as anti-inflammatory agents and as inhibitors of the progressive joint deterioration characteristic of arthritic disease and the methods of meliorating inflammation and of inhibiting joint deterioration in mammals therewith, the novel active ingredients of said compositions of matter being certain substituted cis-2-benozyl-3-hydroxy-2-alkenonitriles and/or the pharmacologically acceptable cationic salts thereof.
REFERENCES:
patent: 3658838 (1972-04-01), Kiehne et al.
patent: 4061767 (1977-12-01), Ertel et al.
Panizzi, Chemical Abstracts, vol. 42, 559-561 (1948).
Vila et al., Chemical Abstracts, vol. 47, 9940 (1952).
Edwards et al., Chemical Abstracts, vol. 50, 1505 (1956).
Hanifin, Jr. John W.
Ridge David N.
American Cyanamid Company
Conroy, Jr. Edward A.
Torrence Dolph H.
LandOfFree
Cis-2-benzoyl-3-hydroxy-2-alkenonitriles as anti-inflammatory ag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cis-2-benzoyl-3-hydroxy-2-alkenonitriles as anti-inflammatory ag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cis-2-benzoyl-3-hydroxy-2-alkenonitriles as anti-inflammatory ag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-462453